Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $11.93 million. The enterprise value is $4.76 million.
Important Dates
The next estimated earnings date is Friday, November 8, 2024, after market close.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
INDP has 10.20 million shares outstanding. The number of shares has increased by 1.37% in one year.
Shares Outstanding | 10.20M |
Shares Change (YoY) | +1.37% |
Shares Change (QoQ) | +1.20% |
Owned by Insiders (%) | 26.67% |
Owned by Institutions (%) | 5.88% |
Float | 7.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.62 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.88 |
Quick Ratio | 3.79 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -127.04% and return on invested capital (ROIC) is -81.94%.
Return on Equity (ROE) | -127.04% |
Return on Assets (ROA) | -71.12% |
Return on Capital (ROIC) | -81.94% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.25M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.41% in the last 52 weeks. The beta is 1.13, so INDP's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | -48.41% |
50-Day Moving Average | 1.40 |
200-Day Moving Average | 1.94 |
Relative Strength Index (RSI) | 42.95 |
Average Volume (20 Days) | 303,342 |
Short Selling Information
The latest short interest is 30,930, so 0.30% of the outstanding shares have been sold short.
Short Interest | 30,930 |
Short Previous Month | 34,151 |
Short % of Shares Out | 0.30% |
Short % of Float | 0.41% |
Short Ratio (days to cover) | 1.32 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.48M |
Pretax Income | -15.75M |
Net Income | -15.75M |
EBITDA | -16.48M |
EBIT | -16.48M |
Earnings Per Share (EPS) | -$1.86 |
Full Income Statement Balance Sheet
The company has $7.30 million in cash and $130,802 in debt, giving a net cash position of $7.17 million or $0.70 per share.
Cash & Cash Equivalents | 7.30M |
Total Debt | 130,802 |
Net Cash | 7.17M |
Net Cash Per Share | $0.70 |
Equity (Book Value) | 6.17M |
Book Value Per Share | 0.72 |
Working Capital | 5.56M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -12.75M |
Capital Expenditures | n/a |
Free Cash Flow | -12.75M |
FCF Per Share | -$1.25 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |